This shift reflects a more mature interpretation of the evidence: the risk is not uniform across all GLP-1 users
While patients living with chronic life-threatening conditions like Type 2 diabetes may accept these risks, people using GLP-1 drugs for less life-threatening and severe purposes like obesity may be less forgiving if the side effects outweigh the perceived benefits
Rivera FB, Cruz LLA, Magalong JV, et al
People with diabetes or insulin resistance, since GH can raise blood sugar and lower insulin sensitivity
This peptide combination is a strong option for people looking to improve energy, recovery, and overall wellness in a natural way
Sikiri, P., Mazul, B., Seiwerth, S., Grabarevi, Z., Rucman, R., Petek, M., Jagi, V., Turkovi, B., Rotkvi, I., Mise, S., Zorici, I., Jurina, L., Konjevoda, P., Hanzevacki, M., Gjurasin, M., Separovi, J., Ljubanovi, D., Artukovi, B., Bratuli, M., Tisljar, M., Sumajstorci, J